Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and NeckGabrielle van Caloen, Jean‐Pascal Machiels|Cancers|2021Cited by 11